PBM NASDAQ
Psyence Biomedical Ltd.
1W: -2.7%
1M: +23.8%
3M: +76.8%
YTD: +575.8%
1Y: +75.1%
$5.16
-0.32 (-5.84%)
Weekly Expected Move ±11.3%
$4
$5
$5
$6
$7
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$4K
-1678.3% ▼
Operating Income
-$4M
-33.1% ▼
Net Income
$1M
+102.0% ▲
3Y CAGR: -50.3%
EPS (Diluted)
$1.78
+122.7% ▲
3Y CAGR: +92.4%
EBITDA
$1M
+102.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $240 | $4K |
| Gross Profit | $0 | $0 | -$240 | -$4K |
| Gross Margin | — | — | — | — |
| R&D Expenses | $137K | $2M | $955K | $342K |
| SG&A Expenses | $2M | $2M | $2M | $3M |
| Operating Expenses | $334K | $1M | $3M | $4M |
| Operating Income | -$334K | -$1M | -$3M | -$4M |
| Operating Margin | — | — | — | — |
| Interest Expense | $0 | $0 | $53K | $9K |
| Income Before Tax | $8M | $8M | -$51M | $1M |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $8M | $8M | -$51M | $1M |
| Net Margin | — | — | — | — |
| EPS (Diluted) | $0.25 | $-0.64 | $-7.85 | $1.78 |
| EBITDA | -$334K | -$1M | -$51M | $1M |
| Shares Outstanding | 33M | 33M | 7M | 568018 |